ERBB2 and gastric cancer: ARX-788 is another HER2-targeted ADC combined with MMAF [99,100], while ALT-P7 [102] as well as ZW-49 [104] are both conjugated with MMAE, but all of these were under investigation for the treatment of breast cancer and/or gastric cancer [8].